Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about ATF3: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
ATF3 is an entity related to neurodegeneration research. Key relationships include: activates, therapeutic target, regulates. Associated with ALS, Aging, Als. Connected to 242 entities in the SciDEX knowledge graph.
No AI portrait yet
Knowledge base pages for this entity
graph TD
ATF3["ATF3"] -->|"regulates"| TREM2["TREM2"]
ATF3["ATF3"] -->|"exacerbates"| neurodegeneration["neurodegeneration"]
ATF3["ATF3"] -->|"activates"| Aging["Aging"]
ATF3["ATF3"] -->|"activates"| Cardiovascular["Cardiovascular"]
ATF3["ATF3"] -->|"activates"| Fibrosis["Fibrosis"]
ATF3["ATF3"] -->|"therapeutic target"| Fibrosis_1["Fibrosis"]
MYO7A["MYO7A"] -->|"activates"| ATF3["ATF3"]
MAP1LC3B["MAP1LC3B"] -->|"activates"| ATF3["ATF3"]
OPTN["OPTN"] -->|"activates"| ATF3["ATF3"]
PARKIN["PARKIN"] -->|"activates"| ATF3["ATF3"]
style ATF3 fill:#006494,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| lipid peroxidation products | increases_risk | mechanism | 0.85 |
| Als | activates | disease | 0.85 |
| mitochondrial dysfunction | associated_with | mechanism | 0.80 |
| Fibrosis | activates | disease | 0.75 |
| Colorectal Cancer | therapeutic_target | disease | 0.75 |
| Cancer | therapeutic_target | disease | 0.75 |
| Als | therapeutic_target | disease | 0.75 |
| NF-kB signaling | participates_in | pathway | 0.70 |
| neurons | expressed_in | cell_type | 0.70 |
| Ferroptosis | activates | pathway | 0.70 |
| Ischemia | activates | disease | 0.65 |
| Ms | activates | disease | 0.65 |
| Tumor | therapeutic_target | disease | 0.65 |
| Inflammation | activates | disease | 0.65 |
| Metabolic Syndrome | activates | disease | 0.65 |
| Stroke | activates | disease | 0.65 |
| Hepatitis | activates | disease | 0.65 |
| Carcinoma | therapeutic_target | disease | 0.65 |
| Inflammation | therapeutic_target | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| Als | associated_with | disease | 0.65 |
| Ms | regulates | disease | 0.65 |
| Fibrosis | therapeutic_target | disease | 0.65 |
| Hepatitis | therapeutic_target | disease | 0.65 |
| Tumor | regulates | disease | 0.65 |
| Aging | activates | disease | 0.65 |
| Tumor | expressed_in | disease | 0.65 |
| Cancer | expressed_in | disease | 0.65 |
| ALS | associated_with | disease | 0.65 |
| Neurodegeneration | regulates | disease | 0.65 |
| Glaucoma | regulates | disease | 0.65 |
| Als | expressed_in | disease | 0.65 |
| Carcinoma | expressed_in | disease | 0.65 |
| Als | regulates | disease | 0.65 |
| Alzheimer | regulates | disease | 0.65 |
| Hepatocellular Carcinoma | therapeutic_target | disease | 0.65 |
| Prostate Cancer | therapeutic_target | disease | 0.65 |
| Aging | causes | disease | 0.65 |
| Pulmonary Fibrosis | therapeutic_target | disease | 0.65 |
| Pancreatic Cancer | therapeutic_target | disease | 0.65 |
| Gastric Cancer | therapeutic_target | disease | 0.65 |
| Tumor | activates | disease | 0.65 |
| Senescence | activates | disease | 0.65 |
| Atherosclerosis | activates | disease | 0.65 |
| Carcinoma | activates | disease | 0.65 |
| Cardiovascular | activates | disease | 0.65 |
| Cardiovascular | associated_with | disease | 0.65 |
| Infection | therapeutic_target | disease | 0.65 |
| Liver Cancer | therapeutic_target | disease | 0.65 |
| ALS | regulates | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| SIRT1 | activates | unknown | 0.95 |
| NAD+ depletion | activates | mechanism | 0.95 |
| CANCER | therapeutic_target | gene | 0.70 |
| FERROPTOSIS | activates | gene | 0.70 |
| GENES | activates | gene | 0.70 |
| OPTINEURIN | activates | gene | 0.60 |
| TOMM20 | activates | gene | 0.60 |
| HSP60 | activates | gene | 0.60 |
| GRIA2 | activates | gene | 0.60 |
| COX4I1 | activates | gene | 0.60 |
| NFKB1 | associated_with | gene | 0.60 |
| ASC | activates | gene | 0.60 |
| MICROGLIA | activates | gene | 0.60 |
| ASTROCYTES | activates | gene | 0.60 |
| INFLAMMATION | activates | gene | 0.60 |
| ZFP36 | activates | gene | 0.60 |
| HSPB1 | activates | gene | 0.60 |
| CH25H | activates | gene | 0.60 |
| APOPTOSIS | regulates | gene | 0.60 |
| ALZHEIMER | regulates | gene | 0.60 |
| ALZHEIMER'S DISEASE | regulates | gene | 0.60 |
| GENES | regulates | gene | 0.60 |
| MICRORNAS | protects_against | gene | 0.60 |
| PRKN | activates | gene | 0.60 |
| ATP | activates | gene | 0.60 |
| MIRNAS | associated_with | gene | 0.60 |
| ABCB1 | targets | gene | 0.60 |
| ALDH1A1 | targets | gene | 0.60 |
| AND | activates | gene | 0.60 |
| GATA2 | protects_against | gene | 0.60 |
| STAT3 | regulates | gene | 0.60 |
| PPARG | protects_against | gene | 0.60 |
| ESR1 | regulates | gene | 0.60 |
| NFKB1 | protects_against | gene | 0.60 |
| BANG | regulates | gene | 0.60 |
| NR3C1 | protects_against | gene | 0.60 |
| MAVS | activates | gene | 0.60 |
| DHODH | activates | gene | 0.60 |
| HSPD1 | activates | gene | 0.60 |
| CEBPA | protects_against | gene | 0.60 |
| PTGS2 | associated_with | gene | 0.60 |
| NR3C1 | associated_with | gene | 0.60 |
| BAX | associated_with | gene | 0.60 |
| BCL2 | associated_with | gene | 0.60 |
| AUTOPHAGY | activates | gene | 0.60 |
| APOPTOSIS | activates | gene | 0.60 |
| INS | regulates | gene | 0.60 |
| ASK1 | activates | gene | 0.60 |
| LONP1 | activates | gene | 0.60 |
| CASP3 | associated_with | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning ATF3 in their description or question text
No additional research found